The size of the Asia Pacific Specialty Enzymes market is developing at a rapid pace.
The demand for specialty enzymes is significantly in the Asia Pacific region. It can be used in the therapies for chronic diseases such as cancer, cardiovascular diseases, and inflammatory diseases, primarily driving growth to the market in this region. The growing aging population, introduction of various drug cosmetics, and protein technologies are further estimated to boost the growth rate of the market.
Increasing funds and investments towards the R & D for the new digestive aids and the growing number of mergers and acquisitions happening between the companies operating in this market are further likely to accelerate the market growth.
Safety concerns related to the high exposure of enzymes towards contamination may impede market growth during the analysis period. The high sensitivity of enzymes to temperature & pH will turn as an obstacle to market growth. Moreover, the high costs associated with the maintenance of these specialty enzyme products are a significant challenge for the companies dealing in this market. Ethical and legal issues regarding the benefits of specialty enzymes and lack of knowledge among the consumers amid the developing economies are also considerable restraints to the market.
This research report on the Asia Pacific Specialty Enzymes market has been segmented and sub-segmented into the following categories:
Regional Analysis:
China and India are likely to increase the market because of the enormous population, and also the Asia Pacific is the largest growing segment. This region is the third-largest region across the globe and is the quickest growing region due to new product launches with wide applications.
China is leading the Asia Pacific specialty enzymes market due to the rising expenses in the healthcare sector, usage of enzymes in various applications like food, cosmetics, pharmaceuticals and leather, and many more applications. India's market for specialty enzymes is predicted to have robust growth by 2025. The proteases enzyme is considered to have rapid growth in the country during the assessment period. The specialty enzymes dominate the Indian market with application pharmaceuticals due to research and development across the recombinant procedures in enhancing the yields of enzymes along with fermentation, growing stability, and altered specificity. Japan is said to be followed after
The Top companies leading in the APAC Specialty Enzymes Market profiled in the report are Bbi Enzymes Ltd., Basf, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Advanced Enzyme Technology Ltd. Affymetrix Inc., Advanced Enzyme Technology Ltd., Amano Enzyme Inc., Roche Holding Ag., and Sanofi S.A. are the leaders in the Asia Pacific Specialty Enzymes market.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Source
5.1.1 Introduction
5.1.2 Micro-Organisms
5.1.3 Plants
5.1.4 Animals
5.1.5 Y-o-Y Growth Analysis, By Source
5.1.6 Market Attractiveness Analysis, By Source
5.1.7 Market Share Analysis, By Source
5.2 Type
5.2.1 Introduction
5.2.2 Carbohydrases
5.2.2.1 Amylases
5.2.2.2 Cellulases
5.2.2.3 Other Carbohydrases
5.2.3 Proteases
5.2.4 Polymerases &Nucleases
5.2.5 Lipases
5.2.6 Others
5.2.7 Specialty Enzymes Used in Pharmaceuticals
5.2.8 Specialty Enzyme Used in Diagnostics
5.2.9 Specialty Enzyme Used For Research & Biotechnology
5.2.10 Y-o-Y Growth Analysis, By Type
5.2.11 Market Attractiveness Analysis, By Type
5.2.12 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Pharmaceuticals
5.3.2.1 Enzyme Replacement Therapy
5.3.2.2 Thrombolytic Enzymes
5.3.2.3 Digestive Enzymes
5.3.3 Research & Biotechnology
5.3.4 Diagnostic
5.3.5 Bio-Catalyst
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Source
6.1.3.3 By Type
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Source
6.1.4.3 By Type
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Source
6.1.5.3 By Type
6.1.5.4 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Affymetrix Inc.
8.1.1 Overview
8.1.2 Source Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 BBI Enzymes Ltd.
8.3 Nagase & Co. Ltd.
8.4 Life Technologies
8.5 Advanced Enzyme Technology Ltd.
8.6 Roche Holding Ag
8.7 Sanofi S.A.
8.8 Codexis Inc.
8.9 Amano Enzyme Inc.
8.10 BASF
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
